← Open Payments lookup

MISTY WITTEN: Open Payments

NPI 1427449305 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$534 in 17 payments from 12 companies in 2025. Trend: 2023 $230 · 2024 $695 · 2025 $534

Food & beverage: $534
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP2$146
GlaxoSmithKline, LLC.4$82
CSL Behring2$67
Takeda Pharmaceuticals U.S.A., Inc.1$35
Regeneron Healthcare Solutions, Inc.1$33
Pharmacosmos Therapeutics Inc.1$28
Daiichi Sankyo Inc.1$27
Vanda Pharmaceuticals Inc.1$26
Chiesi USA, Inc.1$26
ABBVIE INC.1$23

Products named: FASENRA, Hizentra, NUCALA, BENLYSTA, VPRIV, EVKEEZA, MONOFERRIC, INJECTAFER.

Industry payments across TX — which companies pay providers there.